These Analysts Revise Their Forecasts On Abbott Following Q3 Results
benzinga.com/news/25/10/48257211/these-analysts-revise-their-forecasts-on-abbott-following-q3-results
Abbott Laboratories (NYSE:ABT) reported muted sales in the third quarter and narrowed fiscal 2025 guidance on Wednesday.
The company reported third-quarter sales of $11.37 billion, slightly missing the consensus of $11.40 billion. The U.S. MedTech giant reported adjusted earnings of…
This story appeared on benzinga.com, 2025-10-16 16:50:42.